GRAL GRAIL, Inc.

99.25USD-5.33%Mkt Cap: 4.46B USDP/E: —

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individ…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap4.46B USD
Enterprise Value4.01B USD
Revenue (TTM)166.60M USD
Gross Profit-62.57M USD
Net Income (TTM)-408.35M USD
Revenue/Share3.80 USD
Last Price99.25 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees910
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-12.19
PEG—
EV/EBITDA-10.07
EV/Revenue24.08
P/S26.79
P/B1.81
EPS (TTM)-9.22 USD
EPS (Forward)-8.14 USD
52W Range
41.5046% of range166.48
52W High166.48 USD
52W Low41.50 USD
Profitability
Gross Margin-42.52%
Oper. Margin-332.04%
EBITDA Margin-239.08%
Profit Margin-277.47%
ROE-15.84%
ROA-13.97%
ROIC-23.61%
ROCE-18.79%
Growth
Revenue Growth3.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-299.01M USD
CapEx (TTM)909.00K USD
FCF Margin-67.61%
FCF Yield-2.52%
Net Debt-702.83M USD
Net Debt/EBITDA1.76
Net Debt/FCF—
Balance Sheet
Debt/Equity0.02
Current Ratio8.93
Quick Ratio8.56
Book Value/Sh54.82 USD
Cash/Share17.54 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)139.44 USD
Upside (mean)+40.5%
Target Range100.00 USD – 175.00 USD
100.00+40.5% to mean175.00
# Analysts9
Ownership
Shares Out.44.96M
Float34.73M
Insiders4.76%
Institutions85.72%
Short Interest
Short Ratio7.8d
Short % Float18.16%
Short % Out.17.87%
Shares Short8.00M
Short (prev mo.)8.01M
Technical
SMA 50122.96 (-19.3%)
SMA 20079.28 (+25.2%)
Beta2.87
S&P 52W Chg12.00%
Avg Vol (30d)837.32K
Avg Vol (10d)791.88K
Technical Indicators
RSI (14)35.8
MACD-6.7845
MACD Signal-2.6621
MACD Hist.-4.1225
BB Upper164.03 USD
BB Middle127.08 USD
BB Lower90.13 USD
BB Width58.16%
ATR (14)10.50 USD
Vol Ratio (20d)0.82x

About GRAIL (NASDAQ: GRAL)

›

GRAIL (NASDAQ: GRAL) is listed on Nasdaq, where its shares trade in USD. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 910 employees.

The shares were at 99.25 USD on 20 November 2026, up 24.0% over 52 weeks. Its 52-week range is 41.50 USD to 166.48 USD: the price is 40.4% below the high and 139.2% above the low.

Its market capitalisation is 4.46B USD.

GRAIL reports return on equity of -15.8%, an operating margin of -332.0% and revenue up 3.7% year over year.

It holds more cash than debt, a net cash position of 702.83M USD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 9 analysts cover the stock, with an average rating of Buy; their mean price target of 139.44 USD is 40.5% above the current price. The next earnings report is expected on 18 February 2027.